The authors report on a randomized, multicenter, open-label, clinical trial involving 500 patients with 1460 saphenous vein grafts (SVG) who were assigned to three groups: (1) ticagrelor + asprin (ASA), (2) ticagrelor alone, or (3) ASA alone. Neither patients nor physicians were blinded to the allocation. The primary outcome was SVG patency at one
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease
April 20, 2018
The authors present the 5-year follow-up results of the HYBRID trial, wherein 200 patients with multivessel disease requiring revascularization were randomized to either conventional coronary artery bypass grafting (CABG) or hybrid coronary revascularization (HCR). Notably, the patients undergoing HCR had a LIMA to LAD via a minimally invasive appr
April 6, 2018
Patient Care
A baby in Taiwan is the third-lightest to have undergone repair of a type A interrupted aortic arch and aortopulmonary window.
April 4, 2018
Filmed at the 2017 EACTS Annual Meeting in Vienna, Austria, Leanne Harling moderates a discussion with David Taggart and Phillippe Kolh on the future of coronary revascularization.
March 30, 2018
Patient CareHigher risk of death from coronary artery disease was noted for Americans who drank higher quantities of sugary beverages but not for those who ate more sugary foods.
March 13, 2018
This video demonstrates two separate techniques for anastomosis when performing a totally robotic coronary artery bypass without the use of cardiopulmonary bypass.
March 5, 2018
A few months after its publication, the ORBITA trial results do not seem to have filtered adequately to cardiac multidisciplinary teams worldwide.
March 1, 2018
The authors present a thorough expert consensus review on the prevention—preoperative, intraoperative, and postoperative—and the postoperative management of sternal wound infections. The authors conclude with a guideline with class recommendations and levels of evidence.
This article should be in every cardiac surgeon's armamentarium.
March 1, 2018
This single-center group retrospectively reviewed their experience (2004-2014) with at least two arterial conduits for triple-vessel coronary artery disease to assess the benefit of adding a third arterial conduit versus a venous conduit to the right-sided circulation. A total of 167 propensity-matched pairs were compared. In this small study compa
February 28, 2018
The Mayo Clinic team retrospectively reviewed their experience with isolated CABG for multivessel coronary artery disease over a 15-year period to assess usage of bilateral internal mammary arteries (BIMA) and selected outcomes. The population included a total of 6468 isolated CABG procedures.